Henry Ford Quietly Halts Study on Hydroxychloroquine -- A Drug Trump Once Hailed as Covid Game Changer

January 12, 2021, 11:32 AM


Earlier during the pandemic, President Donald Trump hailed hydroxychloroquine as a wonder drug to fight off Covid. In fact, at one point, he said he was taking it prophylactically.

But talk of the drug's effectiveness has faded, and now Henry Ford Health System officials tells Bridge Michigan it has ended its study on the drug after failing to get enough participants.

The  antimalarial drug, which is also used to treat rheumatoid arthritis, lupus and other inflammatory diseases, was hailed by folks like Trump as a game changer. But multiple medical studies eventually concluded it was not effective in treating or preventing the spread of Covid. 

The Henry Ford study was supposed to include 3,000 health care workers, first responders, public transit drivers, or family members of health workers to determine whether hydroxychloroquine would prevent Covid on the frontlines.

But only 624 people signed up, and the study quietly ended a few weeks ago, just before Christmas, Bridge reports. 


Read more:  Bridge Magazine

Leave a Comment:

Photo Of The Day